Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tropicamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,545Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eyenovia Announces Taiwan Export License Approval
    Eyenovia Announces Taiwan Export License Approval

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941189/0/en/Eyenovia-Announces-Taiwan-Export-License-Approval-to-Commence-Shipment-of-Clobetasol-Propionate-Ophthalmic-Suspension-0-05-to-the-U-S.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Eyenovia To Participate In H.C. Wainwright Ophthalmology Conference
    Eyenovia To Participate In H.C. Wainwright Ophthalmology Conference

    13 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/13/2929043/0/en/Eyenovia-to-Participate-in-the-H-C-Wainwright-4th-Annual-Ophthalmology-Virtual-Conference.html

    GLOBENEWSWIRE
    13 Aug 2024
    Share Share
    Enforcement Report - Week of December 6, 2023
    Enforcement Report - Week of December 6, 2023

    06 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2023-46648.pdf

    FDA
    06 Dec 2023
    Share Share
    Enforcement Report - Week of October 25, 2023
    Enforcement Report - Week of October 25, 2023

    25 Oct 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf

    FDA
    25 Oct 2023
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Eyenovia Announces FDA Approval of Mydcombi„¢, the First Ophthalmic Spray
    Eyenovia Announces FDA Approval of Mydcombi„¢, the First Ophthalmic Spray

    08 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/08/2663251/0/en/Eyenovia-Announces-FDA-Approval-of-Mydcombi-the-First-Ophthalmic-Spray-for-Mydriasis-Which-Also-Leverages-the-Company-s-Proprietary-Optejet-Device-Platform.html

    GLOBENEWSWIRE
    08 May 2023
    Share Share